Medicines for Europe Leadership Team on Generics Industry COVID…
In conversation with PharmaBoardroom Christoph Stoller and Adrian Van den Hoven of Medicines for Europe, the association representing the European…
Tagged with Medicines for Europe
Christoph Stoller – President & Adrian van den Hoven…
In the wake of the publication of Medicines for Europe’s Lessons Learned from COVID-19 policy paper, Christoph Stoller & Adrian van den Hoven…
Arun Narayan – Chairman, Value Added Medicines Group,…
Arun Narayan is the Chairman of the Value Added Medicines Sector Group at Medicines for Europe, in addition to serving as Head of Global Portfolio…
Biosimilar Uptake in Europe: Big Challenges; Bigger Rewards
Isabell Remus, chair of the Biosimilar Medicines Group at Medicines for Europe outlines the issues that need to be addressed to keep driving…
Christoph Stoller of Medicines for Europe on Tackling Drug…
Christoph Stoller, general manager for Austria and Germany at Teva was recently elected president of Medicines for Europe, the continent-wide…
Christoph Stoller – President & Adrian van den Hoven…
Christoph Stoller, the recently appointed president of Medicines for Europe, outlines the mission of his presidency, how the association and its…
Adrian van den Hoven – Director General, Medicines for…
Over the last ten years, generic medicines have increased access to medicines by over 100% in 7 key therapeutic areas and have provided massive…
